Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Abaxis
So what: The company, which provides blood diagnostic services, came in with record quarterly revenue of $40 million, and earnings per share of $0.15. Both figures bested expectations, as the market was looking for $37.9 million in sales and $0.14 in earnings per share.
Now what: Revenue showed a 13% increase, bolstered by strength in the veterinary market, which saw an 18% jump in sales. Total instrument unit sales jumped 24%, while international sales growth approached 40%. Management was particularly pleased with growth in Europe and Asia and saw the results in those regions as positive signs of future prospects.
Interested in more info on Abaxis? Add it to your watchlist by clicking here.